Shared genetic architecture between Alzheimer’s disease and blood pressure implicates ACE and NBEAL1 in individuals of European ancestry

Alzheimer's disease is a condition that slowly erodes memory and thinking, eventually stealing a person's ability to care for themselves. For decades, scientists have focused on the brain's own internal failures, looking for the sticky proteins and tangled fibers that clog neural pathways. Yet, a growing body of evidence suggests that the health of the blood vessels supplying the brain plays an equally critical role. Blood pressure, the force of blood pushing against artery walls, is a vital sign that fluctuates throughout life. High pressure can damage delicate vessels, while low pressure might starve the brain of oxygen. While doctors have long known that blood pressure problems often accompany memory loss, the biological bridge connecting the two has remained a mystery. It was unclear whether the genes that control blood pressure also directly influence the risk of developing Alzheimer's, or if the two conditions simply happen to occur together by chance.

A team of researchers set out to map this hidden connection by looking directly at the genetic code. They focused on people of European ancestry, comparing the DNA of individuals with Alzheimer's disease against the DNA of millions of people with varying blood pressure levels. Instead of treating the entire genome as a single block, the scientists examined specific neighborhoods within the DNA to see if certain regions controlled both conditions simultaneously. They used a method that acts like a high-powered microscope for genetics, allowing them to spot tiny overlaps that broader studies had missed. Their goal was to find specific genetic switches that, when flipped, might affect both how the heart pumps blood and how the brain ages.

The researchers discovered that the link between blood pressure and Alzheimer's is not a single, uniform force but a collection of distinct, localized connections. While a broad scan of the entire genome showed only a faint relationship, zooming in on specific DNA regions revealed eight distinct areas where the two conditions strongly overlap. In these specific spots, the genetic instructions for regulating blood pressure and the instructions for brain health are intertwined. The study identified 42 high-confidence genetic variants across these regions that appear to drive this shared risk. Among the most significant findings were genes already known to be important in the disease, such as APOE, which is the strongest known genetic risk factor for Alzheimer's, and ACE, a gene central to blood pressure control. The presence of these familiar genes confirmed that the researchers were on the right track, validating their method of looking for local genetic overlaps.

However, the study also uncovered new players that had not been previously highlighted in this specific context. One gene, NBEAL1, showed a particularly strong connection to pulse pressure, which is the difference between the top and bottom numbers of a blood pressure reading. This gene is involved in how the body handles fats and lipids in the arteries, suggesting that the way blood vessels stiffen with age might be a direct pathway to brain decline. Another gene, SPI1, appeared to link the two conditions through the immune system, hinting that inflammation in the blood vessels could trigger inflammation in the brain. A third gene, NDUFAF6, pointed toward the mitochondria, the tiny power plants inside our cells, suggesting that energy production failures might be a shared weakness in both the heart and the brain.

The researchers did not stop at identifying these genes; they also tested whether changes in blood pressure could actually cause changes in Alzheimer's risk at these specific locations. Using a technique that treats genetic variants as natural experiments, they found evidence that blood pressure levels do indeed influence Alzheimer's risk in several of these regions. The strongest evidence pointed to the APOE region and the ACE region, where blood pressure traits showed a clear causal effect on the disease. This suggests that managing blood pressure might not just be a general health recommendation but a targeted strategy that could work through specific biological pathways to protect the brain.

Despite these promising leads, the authors are careful to note that their findings are a map of potential pathways rather than a finished blueprint for a cure. The study was limited to people of European ancestry, meaning these genetic connections might look different in other populations. Furthermore, while the data strongly suggests that these genes are involved, it does not yet prove exactly how they interact or which specific cell types are most affected. The researchers emphasize that the relationship between blood pressure and Alzheimer's is complex, involving multiple distinct mechanisms rather than a single cause. Some pathways are shared across all types of blood pressure, while others are specific to systolic pressure, diastolic pressure, or pulse pressure. This complexity implies that a one-size-fits-all approach to prevention might not be enough; instead, future treatments may need to be tailored to the specific genetic and vascular profile of each patient.

Ultimately, this work shifts the conversation from a vague association between heart health and brain health to a precise genetic understanding of how they are linked. By pinpointing specific genes like NBEAL1, SPI1, and NDUFAF6, the study offers new targets for scientists to investigate. These genes provide a starting point for understanding how vascular dysfunction accelerates neurodegeneration. The findings suggest that the story of Alzheimer's is not just written in the brain's neurons but is also deeply rooted in the blood vessels that feed them. As researchers continue to explore these genetic intersections, the hope is that they can develop better ways to predict who is at risk and design therapies that address the specific vascular mechanisms driving the disease.